
Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity
Leukemia, Published online: 16 June 2026; doi:10.1038/s41375-026-03004-2Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity

Leukemia, Published online: 16 June 2026; doi:10.1038/s41375-026-03004-2Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity
Leukemia, Published online: 15 June 2026; doi:10.1038/s41375-026-03007-zResponse kinetics as a dynamic prognostic marker in patients with multiple myeloma

Leukemia, Published online: 15 June 2026; doi:10.1038/s41375-026-02993-4Allogeneic hematopoietic cell transplantation for T-cell/histiocyte-rich large B-cell lymphoma: An EBMT lymphoma working party s
Leukemia, Published online: 15 June 2026; doi:10.1038/s41375-026-02992-5Can natural killer cells cure leukemia?
Leukemia, Published online: 15 June 2026; doi:10.1038/s41375-026-02996-1Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia

Leukemia, Published online: 11 June 2026; doi:10.1038/s41375-026-03002-4Direct measurement of in vivo BCR::ABL1 kinase inhibition reveals stronger potency of asciminib as compared with imatinib and ni